You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR REVEFENACIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for REVEFENACIN

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01704404 ↗	7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease	Completed	Theravance Biopharma	Phase 2	2012-12-01	This study will characterize the dose response of TD-4208 after 7 days of dosing in subjects with Chronic Obstructive Pulmonary Disease (COPD).
NCT01704404 ↗	7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease	Completed	Mylan Inc.	Phase 2	2012-12-01	This study will characterize the dose response of TD-4208 after 7 days of dosing in subjects with Chronic Obstructive Pulmonary Disease (COPD).
NCT01704404 ↗	7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease	Completed	Theravance Biopharma R & D, Inc.	Phase 2	2012-12-01	This study will characterize the dose response of TD-4208 after 7 days of dosing in subjects with Chronic Obstructive Pulmonary Disease (COPD).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for REVEFENACIN

Condition Name

Chart
Table

Condition Name for REVEFENACIN
Intervention	Trials
Chronic Obstructive Pulmonary Disease (COPD)	5
COPD	5
Chronic Obstructive Pulmonary Disease, COPD	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for REVEFENACIN
Intervention	Trials
Pulmonary Disease, Chronic Obstructive	12
Lung Diseases, Obstructive	12
Lung Diseases	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for REVEFENACIN

Trials by Country

Map
Table

Trials by Country for REVEFENACIN
Location	Trials
United States	32
New Zealand	2
China	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for REVEFENACIN
Location	Trials
South Carolina	6
Florida	4
Oregon	3
North Carolina	3
Tennessee	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for REVEFENACIN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for REVEFENACIN
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	6
Phase 2	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for REVEFENACIN
Clinical Trial Phase	Trials
Completed	14
Recruiting	2
Not yet recruiting	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for REVEFENACIN

Sponsor Name

Chart
Table

Sponsor Name for REVEFENACIN
Sponsor	Trials
Mylan Inc.	17
Theravance Biopharma	16
Theravance Biopharma R & D, Inc.	12
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for REVEFENACIN
Sponsor	Trials
Industry	48
Other	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.